HEPATECELLULAR CARCINOMA
Clinical trials for HEPATECELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HEPATECELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for HEPATECELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough liver cancer: combo therapy targets tumors with vein clots
Disease control Recruiting nowThis study tests a combination of two immunotherapy drugs (iparomlimab and tuvonralimab, together called QL1706), a targeted therapy (bevacizumab), and chemotherapy given directly into the liver artery for people with advanced liver cancer that has spread into the main portal vei…
Matched conditions: HEPATECELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
AI model aims to predict liver cancer recurrence in Early-Stage patients
Knowledge-focused Recruiting nowThis study tests whether an AI model can accurately predict if early-stage liver cancer will come back within 2 years after surgery. Researchers will follow 353 patients who have surgery, using their medical data and scans to train and validate the AI. The goal is to identify hig…
Matched conditions: HEPATECELLULAR CARCINOMA
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 06:52 UTC